DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Botulinum Toxin Market Analysis By Type (Botulinum Toxin Type A, Botulinum Toxin Type B), By End Use (Therapeutic, Aesthetic), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2013 - 2025" report to their offering.
The global botulinum toxin (BNT) market is expected to reach a value of USD 7.3 billion by 2025. The constant introduction of innovative products for enhancement of aesthetic appeal supporting minimally invasive aesthetic treatments is the prime factor driving the growth of the market.
In addition, rapid growth of the sector is attributed to the rising demand for minimally invasive or non-invasive procedures. These procedures provide advantages such as small incision, shorter hospital stay and rapid wound healing, and hence lead to larger acceptance and demand. In addition, availability of wide variety of minimally invasive or non-invasive treatment options is pushing the global botulinum toxin market towards growth.
Also, the successful completion of research projects is expected to expand the applications of presently approved products. Companies are trying to widen the application of botulinum toxin in therapeutic area through various research activities. For instance, Botox by Allergan received the U.S. FDA approval for the treatment of strabismus (crossed eyes) and blepharospasm associated with dystonia in 1989.
Key Topics Covered:
1 Research Methodology
2 Executive Summary
3 Botulinum Toxin Market Variables, Trends & Scope
4 Botulinum Toxin Market: Product Type Estimates & Trend Analysis
5 Botulinum Toxin Market: End Use Estimates & Trend Analysis
6 Botulinum Toxin Market: Regional Estimates &Trend Analysis, by Product Type & End Use
7 Competitive Landscape
- Ipsen group
- Allergan Inc.
- Medytox Inc.
- Merz GmbH and Co. KGaA
- US Worldmed, LLC
- Lanzhou Institute of Biological Products Co. Ltd.
Revance Therapeutics, Inc.
For more information about this report visit http://www.researchandmarkets.com/research/6ljz6q/botulinum_toxin